How do we avoid overtreating skin cancer in people with severe frailty and limited life expectancy?
Powell, James B Dhesi, Jugdeep K Harwood, Catherine A McGrath, Emily J Venables, Zoe C Chua, Ser-Ling Keohane, Stephen G Mallipeddi, Raj Marsden, Jerry R Matin, Rubeta N
Powell, James B
Dhesi, Jugdeep K
Harwood, Catherine A
McGrath, Emily J
Venables, Zoe C
Chua, Ser-Ling
Keohane, Stephen G
Mallipeddi, Raj
Marsden, Jerry R
Matin, Rubeta N
Abstract
No abstract available
MIDER Authors
Affiliations
Wye Valley NHS Trust; Guy’s and St Thomas’ NHS Foundation Trust; British Geriatrics Society; Barts Health NHS Trust; Queen Mary University of London; Royal Devon University Healthcare NHS Foundation Trust; Norfolk and Norwich University Hospitals NHS Foundation Trust; University of East Anglia; University Hospitals Birmingham NHS Foundation Trust; Portsmouth Hospitals University NHS Trust; Oxford University Hospitals NHS Foundation Trust; Nottingham University Hospitals NHS Trust, Nottingham; British Association of Dermatologists
Date
2025-05-15
Type
Article
Subject
Collections
Citation
Powell JB, Dhesi JK, Harwood CA, McGrath EJ, Venables ZC, Chua SL, Keohane SG, Mallipeddi R, Marsden JR, Matin RN, Sharma A, Mohd Mustapa MF. How do we avoid overtreating skin cancer in people with severe frailty and limited life expectancy? Br J Dermatol. 2025 Aug 18;193(3):551-554. doi: 10.1093/bjd/ljaf174.